COVID-19-Related Symptoms assessment

DIAGNOSTIC_TEST2 trials

Sponsors

MGC Pharmaceuticals d.o.o, Code Pharma

Conditions

COVID-19Corona Virus InfectionCovid19

Phase 2

Study Designed to Evaluate the Effect of CimetrA in Patients Diagnosed With COVID-19

CompletedNCT05037162

MGC Pharmaceuticals d.o.oCorona Virus Infection, Covid19

Start: 2022-10-11End: 2023-03-01Updated: 2023-03-15

Phase IIa Randomized Placebo Controlled Clinical Study of Codivir in Hospitalized Patients with Moderate COVID-19

RecruitingNCT05218356

Code PharmaCOVID-19

Start: 2022-01-20End: 2025-07-20Target: 130Updated: 2024-10-02